Evidence map›Paper›PMID 40469194›Full record

ArticleFrontiers in oncology2025

Antiproliferative and pro-apoptotic effects of

Dominika Sebova, Simona Zilakova, Viktoria Medvecova, Michal Goga, Richard Frenak, Annamaria Bardelcikova, Andrej Mirossay, Ladislav Mirossay, Jan Mojzis, Martin Kello

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dominika SebovaDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.
Simona ZilakovaDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.
Viktoria MedvecovaDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.
Michal GogaDepartment of Botany, Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Šafárik University, Kosice, Slovakia.
Richard FrenakDepartment of Botany, Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Šafárik University, Kosice, Slovakia.
Annamaria BardelcikovaDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.
Andrej MirossayDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.
Ladislav MirossayDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.
Jan MojzisDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.
Martin KelloDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Kosice, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mammary gland malignancies are the most diagnosed oncological diseases in women. The currently available treatment faces several problems, including resistance to cytostatics and the relatively high recurrence rates. These limitations have led to an increasing interest in natural substances as potential anticancer agents. Therapeutic approaches using a combination of natural anticancer agent and conventional cytostatic drug could also be beneficial in minimising the risk of chemotherapy. In the present study, we evaluated the anticancer effect of Methods: To investigate the effects of tested compounds, a range of assays were employed. BrdU and clonogenic assays were used to evaluate antiproliferative activity. Flow cytometry and Western blot were used to demonstrate apoptotic cell death, oxidative stress, DNA damage, and immune checkpoint modulation in a time-dependent manner (24, 48, and 72 h). Results: PSE and PHY induced cycle arrest at a G1 checkpoint with modulation of cell cycle-related proteins. Furthermore, activation of intrinsic apoptotic pathway, involving changes in Bcl-2 family proteins, caspase-3/-7 activity, caspase-9 cleavage, cytochrome Conclusions: Treatment with PSE and PHY in BC cells resulted in mitochondrial apoptosis associated with oxidative stress and DNA damage. Furthermore, modulation of immune checkpoint PD-1/PD-L1 was demonstrated. Based on the results, we assume the use of PSE and PHY as promising targeted agents for BC.

Indexed as

apoptosisbreast cancerimmune checkpointsoxidative damagephysodic acidPseudevernia furfuracea

Identifiers

PMID40469194
PMCPMC12133469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.